Abstract
Gastroparesis is a chronic symptomatic disorder of the stomach characterized by delayed emptying without evidence of mechanical obstruction. Symptoms from gastroparesis include nausea, vomiting, early satiety, postprandial fullness, and, in some patients, upper abdominal pain. The three main causes of gastroparesis are diabetic, postsurgical, and idiopathic. Gastroparesis, whatever the etiology, is much more prevalent in females than in males. This chapter will discuss aspects of gastroparesis, particularly idiopathic gastroparesis, with special emphasis to the gender aspects on gastric motility, gastroparesis, symptoms, and treatment. Management of gastroparesis includes assessment and correction of dehydration and malnutrition if present, maintaining nutritional intake, and improvement of symptoms. Diet and nutrition should be managed by oral dietary modifications such as smaller meals, low-fat-containing meals, and low-roughage-containing meals. Medical treatment entails use of prokinetic and antiemetic therapies. For refractory cases, consideration for jejunostomy feeding tube, gastric electric stimulator, and/or pyloromyotomy may need to be considered. Unfortunately, currently approved treatment options do not adequately address the significant clinical need in gastroparesis. Attention should be given to the development of new effective therapies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pathikonda M, Sachdeva P, Malhotra N, Fisher RS, Maurer AH, Parkman HP. Gastric emptying scintigraphy: is four hours necessary? J Clin Gastroenterol. 2012;46(3):209–15.
Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH, McCallum RW, Nowak T, Nusynowitz ML, Parkman HP, Shreve P, Szarka LA, Snape WJ Jr, Ziessman HA, American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol. 2008;103(3):753–63.
Pasricha PJ, Colvin R, Yates K, Hasler WL, Abell TL, Ünalp-Arida A, Nguyen L, Farrugia G, Koch KL, Parkman HP, Snape WJ, Lee L, Tonascia J, Hamilton F. Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. Clin Gastroenterol Hepatol. 2011;9(7):567–76.e1–4.
Pasricha PJ, Yates KP, Nguyen L, Clarke J, Abell TL, Farrugia G, Hasler WL, Koch KL, Snape WJ, McCallum RW, Sarosiek I, Tonascia J, Miriel LA, Lee L, Hamilton F, Parkman HP. Outcomes and factors associated with reduced symptoms in patients with gastroparesis. Gastroenterology. 2015;149(7):1762–1774.e4. https://doi.org/10.1053/j.gastro.2015.08.008.
Hasler WL, Wilson LA, Parkman HP, Koch KL, Abell TL, Nguyen L, Pasricha PJ, Snape WJ, McCallum RW, Sarosiek I, Farrugia G, Calles J, Lee L, Tonascia J, Unalp-Arida A, Hamilton F. Factors related to abdominal pain in gastroparesis. Neurogastroenterol Motil. 2013;25(5):427–38.
Parkman HP, Van Natta ML, Abell TL, McCallum RW, Sarosiek I, Nguyen L, Snape WJ, Koch KL, Hasler WL, Farrugia G, Lee L, Unalp-Arida A, Tonascia J, Hamilton F, Pasricha PJ. Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial. JAMA. 2013;310(24):2640–9.
Parkman HP, Yates KP, Hasler WL, Nguyan L, Pasricha PJ, Snape WJ, Farrugia G, Calles J, Koch KL, Abell TL, McCallum RW, Petito D, Parrish CR, Duffy F, Lee L, Unalp-Arida A, Tonascia J, Hamilton F. NIDDK Gastroparesis Clinical Research Consortium. Dietary intake and nutritional deficiencies in patients with diabetic or idiopathic gastroparesis. Gastroenterology. 2011;141(2):486–498.e1–7. https://doi.org/10.1053/j.gastro.2011.04.045.
Parkman HP, Yates K, Hasler WL, Nguyen L, Pasricha PJ, Snape WJ, Farrugia G, Koch KL, Abell TL, McCallum RW, Lee L, Unalp-Arida A, Tonascia J, Hamilton F, National Institute of Diabetes and Digestive and Kidney Diseases Gastroparesis Clinical Research Consortium. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology. 2011;140(1):101–15.
Friedenberg FK, Palit A, Parkman HP, Hanlon A, Nelson DB. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol. 2008;103(2):416–23.
Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L, American College of Gastroenterology. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108(1):18–37.
Parkman HP, Mishra A, Jacobs M, Pathikonda M, Sachdeva P, Gaughan J, Krynetskiy E. Clinical response and side effects of metoclopramide: associations with clinical, demographic, and pharmacogenetic parameters. J Clin Gastroenterol. 2012;46(6):494–503.
Camilleri M, Shin A. Lessons from pharmacogenetics and metoclopramide: toward the right dose of the right drug for the right patient. J Clin Gastroenterol. 2012;46(6):437–9.
Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2010;31(1):11–9.
Jung HK, Choung RS, Locke GR III, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009;136:1225–33.
Rey E, Choung RS, Schleck CD, et al. Prevalence of hidden gastroparesis in the community: the gastroparesis “iceberg”. J Neurogastroenterol Motil. 2012;18:34–42.
Wang YR, Fisher RS, Parkman HP. Gastroparesis-related hospitalizations in the United States: trends, characteristics, and outcomes, 1995–2004. Am J Gastroenterol. 2008;103:313–22.
Soykan I, Sivri B, Sarosiek I, Kiernan B, McCallum RW. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998;43:2398–404.
Cherian D, Sachdeva P, Fisher RS, Parkman HP. Abdominal pain is a frequent symptom of gastroparesis. Clin Gastroenterol Hepatol. 2010;8:676–81.
Hasler WL, Wilson LA, Parkman HP, et al. Bloating in gastroparesis: severity, impact, and associated factors. Am J Gastroenterol. 2011;106:1492–502.
Parkman HP, Yates K, Hasler WL, et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology. 2011;140(1):101–15.
Parkman HP, Yamada G, Van Natta ML, et al. Ethnic, racial, and sex differences in etiology, symptoms, treatment, and symptom outcomes of patients with gastroparesis. Clin Gastroenterol Hepatol. 2018;17(8):1489–1499.e8.
Dickman R, Wainstein J, Glezerman M, Niv Y, Boaz M. Gender aspects suggestive of gastroparesis in patients with diabetes mellitus: a cross-sectional survey. BMC Gastroenterol. 2014;14:34.
Hawthorne G. Maternal complications in diabetic pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25(1):77–90.
Revicki DA, Rentz AM, Dubois D, et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther. 2003;18:141–50.
Revicki DA, Camilleri M, Kuo B, et al. Development and content validity of a gastroparesis cardinal symptom index daily diary. Aliment Pharmacol Ther. 2009;30:670–80.
Cassilly DW, Wang YR, Friedenberg FK, Nelson DB, Maurer AH, Parkman HP. Symptoms of gastroparesis: use of the gastroparesis cardinal symptom index in symptomatic patients referred for gastric emptying scintigraphy. Digestion. 2008;78(2–3):144–51.
Hasler WL, Wilson LA, Parkman HP, et al. Factors related to abdominal pain in gastroparesis: contrast to patients with predominant nausea and vomiting. Neurogastroenterol Motil. 2013;25(5):427–38, e300-1.
Jehangir A, Abdallah RT, Parkman HP. Characterizing abdominal pain in patients with gastroparesis into neuropathic and nociceptive components. J Clin Gastroenterol. 2019;53(6):427–33.
Hasler WL. Gastroparesis: pathogenesis, diagnosis, and management. Nat Rev Gastroenterol Hepatol. 2011;8:438–53.
Jones KL, Russo A, Stevens JE, et al. Predictors of delayed gastric emptying in diabetes. Diabetes Care. 2001;24:1264–9.
Choung RS, Locke GR III, Schleck CD, Zinsmeister AR, Melton LJ, Talley NJ. Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population. Am J Gastroenterol. 2012;107:82–8.
Koch KL, Hasler WL, Yates KP, Parkman HP, Pasricha PJ, Calles-Escandon J, Snape WJ, Abell TL, McCallum RW, Nguyen LA, Sarosiek I, Farrugia G, Tonascia J, Lee L, Miriel L, Hamilton F, NIDDK Gastroparesis Clinical Research Consortium (GpCRC). Baseline features and differences in 48 week clinical outcomes in patients with gastroparesis and type 1 vs type 2 diabetes. Neurogastroenterol Motil. 2016;28(7):1001–15. https://doi.org/10.1111/nmo.12800. Epub 2016 Mar 6.
Watkins CC, Sawa A, Jaffrey S, et al. Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. J Clin Invest. 2000;106:373.
Habtezion A, Wiley JW. Diabetic gastroparesis: an emerging role for macrophages and heme oxygenase-1. Gastroenterology. 2010;138:2219.
Parkman HP. Assessment of gastric emptying and small-bowel motility: scintigraphy, breath tests, manometry, and SmartPill. Gastrointest Endosc Clin N Am. 2009;19:49–55.
Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol. 2008;103(3):753–63.
Kuo B, McCallum RW, Koch KL, Sitrin MD, Wo JM, Chey WD, Hasler WL, Lackner JM, Katz LA, Semler JR, Wilding GE, Parkman HP. Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther. 2008;27(2):186–96.
Sarosiek I, Selover KH, Katz LA, Semler JR, Wilding GE, Lackner JM, Sitrin MD, Kuo B, Chey WD, Hasler WL, Koch KL, Parkman HP, Sarosiek J, McCallum RW. The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology. Aliment Pharmacol Ther. 2010;31(2):313–22. https://doi.org/10.1111/j.1365-2036.2009.04162.x.
Szarka LA, Camilleri M, Vella A, Burton D, Baxter K, Simonson J, Zinsmeister AR. A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol. 2008;6(6):635–643.e1. https://doi.org/10.1016/j.cgh.2008.01.009.
Horowitz M, Maddox AF, Wishart JM, Harding PE, Chatterton BE, Shearman DJ. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med. 1991;18:229–34.
Pasricha PJ, Colvin R, Yates K, et al. Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. Clin Gastroenterol Hepatol. 2011;9:567–576.e1–4.
Datz FL, Christian PE, Moore J. Gender-related differences in gastric emptying. J Nucl Med. 1987;28:1204–7.
Hutson WR, Roehrkasse RL, Wald A. Influence of gender and menopause on gastric emptying and motility. Gastroenterology. 1989;93:934–40.
Wedmann B, Schmidt G, Wegener M, et al. Effects of age and gender on fat-induced gallbladder contraction and gastric emptying of a caloric liquid meal: a sonographic study. Am J Gastroenterol. 1991;86:1765–70.
Gill RC, Murphey PD, Hooper HR, et al. Effect of the menstrucal cycle on gastric emptying. Digestion. 1987;36:168–74.
Petring OU, Flachs H. Inter and intrasubject variability of gastric emptying in healthy volunteers measured by scintigraphy and paracetamol absorption. Br J Clin Pharmacol. 1990;29:703–8.
Mones J, Carrio I, Calabuig R, et al. Influence of the menstrual cycle and of menopause on the gastric emptying rate of solids in female volunteers. Eur J Nucl Med. 1993;20:600–2.
Horowitz M, Maddern GJ, Chatterton BE, et al. The normal menstrual cycle has no effect on gastric emptying. Br J Obstet Gynecol. 1985;92:743–6.
Bruce LA, Behsudi FM, Danhof IE. Smooth muscle mechanical responses in vitro to bethanechol after progesterone in male rat. Am J Phys. 1978;235:E422–8.
Kumar D. In vitro inhibitory effect of progesterone on extrauterine human smooth muscle. Am J Obstet Gynecol. 1962;84:1300–4.
Koch KL, Stern RM, Vasey M, et al. Gastric dysrhythmias and nausea of pregnancy. Dig Dis Sci. 1990;35:961–8.
Walsh JW, Hasler WL, Nugent CE, Owyang C. Progesterone and estrogen are potential mediators of gastric slow-wave dysrhythmias in nausea of pregnancy. Am J Phys. 1996;270(3 Pt 1):G506–14.
Riezzo G, Pezzolla F, Darconza G, et al. Gastric myoelectrical activity in the first trimester of pregnancy: a cutaneous electrogastrographic study. Am J Gastroenterol. 1992;87:702–7.
Knight LC, Parkman HP, Brown KL, Miller MA, Trate DM, Maurer AH, Fisher RS. Delayed gastric emptying and decreased antral contractility in normal premenopausal women compared with men. Am J Gastroenterol. 1997;92:968–75.
Mearadji B, Penning C, Vu MK, van der Schaar PJ, van Petersen AS, Kamerling IMC, Masclee AAM. Influence of gender on proximal gastric motor and sensory function. Am J Gastroenterol. 2001;96:2066–73.
Heitkemper M, Jarrett M. Irritable bowel syndrome: does gender matter? J Psychosom Res. 2008;64(4):583–7.
Winborn WB, Sheridan PJ, Mcgill HC. Sex steroid receptors in the stomach, liver, pancreas, and gastrointestinal tract of the baboon. Gastroenterology. 1987;92(1):23–32.
Christofides ND, Ghatiei MA, Bloom SR, et al. Decreased plasma motilin concentrations in pregnancy. Br Med J (Clin Res Ed). 1982;285:1453–4.
Zl X, Cao W, Biancani P, Behar J. Nongenomic effects of progesterone on the contraction of muscle cells from the guinea pig colon. Am J Physiol Gastrointest Liver Physiol. 2006;290:G1008–15.
Gangula PRR, Maner WL, Micci M-A, Garfield RE, Pasricha PJ. Diabetes induced sex-dependent changes in neuronal nitric oxide synthase dimerization and function in the rat gastric antrum. Am J Physiol Gastrointest Liver Physiol. 2007;292:G725–33.
Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM, Sonnenberg A, Stanghellini V, Stewart WF, Tack J, Talley NJ, Whitehead W, Revicki DA. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005;3(6):543–52.
Stanghellini V, Tosetti C, Paternico A, Barbara G, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology. 1996;110:1036–42.
Parkman HP, Carlson MR, Gonyer D. Metoclopramide nasal spray reduces symptoms of gastroparesis in women, but not men, with diabetes: results of a phase 2B randomized study. Clin Gastroenterol Hepatol. 2015;13(7):1256–1263.e1.
Moore JG, Christian PE, Brown JA, et al. Influence of meal weight and caloric content on gastric emptying of meals in man. Dig Dis Sci. 1984;29:513–9.
Moore JG, Christian PE, Coleman RE. Gastric emptying of varying meal weight and composition in man. Evaluation by dual liquid- and solid-phase isotopic method. Dig Dis Sci. 1981;26:16–22.
Homko CJ, Duffy F, Friedenberg FK, Boden G, Parkman HP. Effect of dietary fat and food consistency on gastroparesis symptoms in patients with gastroparesis. Neurogastroenterol Motil. 2015;27(4):501–8. https://doi.org/10.1111/nmo.12519.
Wytiaz V, Homko C, Duffy F, Schey R, Parkman HP. Foods provoking and alleviating symptoms in gastroparesis: patient experiences. Dig Dis Sci. 2015;60(4):1052–8. https://doi.org/10.1007/s10620-015-3651-7.
McCallum RW, George SJ. Gastric dysmotility and gastroparesis. Curr Treat Options Gastroenterol. 2001;4:179–91.
Liu N, Abell T. Gastroparesis updates on pathogenesis and management. Gut Liver. 2017;11(5):579–89. Recent updates regarding pathophysiology and management of gastroparesis.
Schey R, Saadi M, Midani D, Roberts AC, Parupalli R, Parkman HP. Domperidone to treat symptoms of gastroparesis: benefits and side effects from a large single-center cohort. Dig Dis Sci. 2016;61(12):3545–51.
Midani D, Parkman HP. Granisetron transdermal system for treatment of symptoms of gastroparesis: a prescription registry study. J Neurogastroenterol Motil. 2016;22(4):650–5. https://doi.org/10.5056/jnm15203.
Pasricha PJ, Yates KP, Sarosiek I, et al. Aprepitant has mixed effects on nausea and reduces other symptoms in patients with gastroparesis and related disorders. Gastroenterology. 2018;154(1):65–76.e11.
Pasricha PJ, Yates K, Sarosiek I, McCallum RW, et al. Aprepitant for symptoms of gastroparesis and related disorders: the apron randomized clinical trial. Am J Gastroenterol. 2016;111:S480–S481.
Heckert J, Sankineni A, Hughes WB, Harbison S, Parkman H. Gastric electric stimulation for refractory gastroparesis: a prospective analysis of 151 patients at a single center. Dig Dis Sci. 2016;61(1):168–75. https://doi.org/10.1007/s10620-015-3837-z.
Chu H, Lin Z, Zhong L, Mccallum RW, Hou X. Treatment of high-frequency gastric electrical stimulation for gastroparesis. J Gastroenterol Hepatol. 2012;27(6):1017–26.
Hibbard ML, Dunst CM, Swanström LL. Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptom improvement. J Gastrointest Surg. 2011;15(9):1513–9.
Benias PC, Khashab MA. Gastric peroral endoscopic pyloromyotomy therapy for refractory gastroparesis. Curr Treat Options Gastroenterol. 2017;15(4):637–47.
Huyi R. Gastroparesis: Clinical Evaluation of Drugs for Treatment Guidance for Industry. Draft Guidance 2015. https://www.fda.gov/media/92791/download.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Shahsavari, D., Parkman, H.P. (2019). Idiopathic Gastroparesis. In: Beniwal-Patel, P., Shaker, R. (eds) Gastrointestinal and Liver Disorders in Women’s Health . Springer, Cham. https://doi.org/10.1007/978-3-030-25626-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-25626-5_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-25625-8
Online ISBN: 978-3-030-25626-5
eBook Packages: MedicineMedicine (R0)